CC
GSK icon

Centiva Capital’s GSK GSK Stock Holding History

Centiva Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,471
Closed -$210K – 1452
2025
Q2 		$210K Buy
+5,471
New +$209K 0.01% 1320
2024
Q4 		– Sell
-14,488
Closed -$592K – 1969
2024
Q3 		$592K Sell
14,488
-9,008
-38% -$369K 0.03% 1133
2024
Q2 		$905K Buy
+23,496
New +$988K 0.04% 833
2022
Q1 		– Sell
-25,034
Closed -$1.38M – 1734
2021
Q4 		$1.38M Buy
+25,034
New +$1.3M 0.09% 477

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.3B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return